Billie, Kimao T.

HRN: 10-07-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/04/2023
02/11/2023
IV
4.5gm
QID
Community Acquired Pneumonia High Risk
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: